209 results on '"Phillips, Richard O"'
Search Results
2. Impact of antibiotic intake on the incidence of extended-spectrum β-lactamase–producing Enterobacterales in sub-Saharan Africa: results from a community-based longitudinal study
3. Genetic diversity of SARS-CoV-2 infections in Ghana from 2020-2021
4. BCG Vaccination-Associated Lower HbA1c and Increased CD25 Expression on CD8+ T Cells in Patients with Type 1 Diabetes in Ghana
5. Haematological Profile and ACE2 Levels of COVID-19 Patients in a Metropolis in Ghana
6. An IL7RA exon 5 polymorphism is associated with impaired IL-7Rα splicing and protection against tuberculosis in Ghana
7. High prevalence of asymptomatic malaria infections in adults, Ashanti Region, Ghana, 2018
8. Monocyte pathology in human tuberculosis is due to plasma milieu changes and aberrant STAT signalling
9. BCG-Vaccinated Children with Contact to Tuberculosis Patients Show Delayed Conversion of Mycobacterium tuberculosis-Specific IFN-γ Release
10. Absence of malaria-associated coagulopathy in asymptomatic Plasmodium falciparum infection: results from a cross-sectional study in the Ashanti region, Ghana
11. T-Cell Responses Against Mycobacterium ulcerans and Mycobacterium tuberculosis Protein Extracts Identify Children With Buruli Ulcer Disease
12. Treatment of Buruli Ulcer
13. Infection with Mansonella perstans nematodes in Buruli ulcer patients, Ghana
14. Rural and Semi-Urban Differences in Salt Intake, and Its Dietary Sources, in Ashanti, West Africa
15. Intestinal Colonization with Tropheryma whipplei—Clinical and Immunological Implications for HIV Positive Adults in Ghana
16. Performance of COVID-19 associated symptoms and temperature checking as a screening tool for SARS-CoV-2 infection
17. Oral treatment for patients with Buruli ulcer co-infected with HIV: think twice
18. Mapping suitability for Buruli ulcer at fine spatial scales across Africa: A modelling study
19. Barriers to Buruli ulcer treatment completion in the Ashanti and Central Regions, Ghana
20. T-Cell Responses Against Mycobacterium ulceransand Mycobacterium tuberculosisProtein Extracts Identify Children With Buruli Ulcer Disease
21. Drug resistance outcomes of long-term ART with tenofovir disoproxil fumarate in the absence of virological monitoring
22. Paradoxical reactions in Buruli ulcer after initiation of antibiotic therapy: Relationship to bacterial load
23. The Efficacy of Doxycycline Treatment on Mansonella perstans Infection: An Open-Label, Randomized Trial in Ghana
24. The paediatric participation scale measuring participation restrictions among former Buruli Ulcer patients under the age of 15 in Ghana and Benin: Development and first validation results
25. Diagnostics for COVID-19: A case for field-deployable, rapid molecular tests for community surveillance.
26. Profile and outcomes of hospitalized patients with COVID-19 at a tertiary institution hospital in Ghana.
27. Pulmonary aspergilloma: An evasive disease
28. High prevalence of multidrug-resistant tuberculosis among patients with rifampicin resistance using GeneXpert Mycobacterium tuberculosis/rifampicin in Ghana
29. An IL7RA exon 5 polymorphism is associated with impaired IL-7Rα splicing and protection against tuberculosis in Ghana
30. IFN-γ and IL-5 whole blood response directed against mycolactone polyketide synthase domains in patients withMycobacterium ulceransinfection
31. Analysis of Mycobacterium ulcerans-specific T-cell cytokines for diagnosis of Buruli ulcer disease and as potential indicator for disease progression
32. Epidemiology of Mansonella perstans in the middle belt of Ghana
33. Former Buruli Ulcer Patients’ Experiences and Wishes May Serve as a Guide to Further Improve Buruli Ulcer Management
34. Short Report: Buruli Ulcer Control in a Highly Endemic District in Ghana: Role of Community-Based Surveillance Volunteers
35. The Efficacy of Doxycycline Treatment on Mansonella perstans Infection: An Open-Label, Randomized Trial in Ghana.
36. Buruli ulcer: Current landscape, challenges, and future directions
37. Experiences of Pain and Expectations for Its Treatment Among Former Buruli Ulcer Patients
38. Genetic Susceptibility and Predictors of Paradoxical Reactions in Buruli Ulcer
39. Next-Generation Sequencing Reveals Frequent Opportunities for Exposure to Hepatitis C Virus in Ghana
40. Metabolomic profiles delineate mycolactone signature in Buruli ulcer disease
41. IFN-γ and IL-5 whole blood response directed against mycolactone polyketide synthase domains in patients with Mycobacterium ulcerans infection.
42. An IL7RAexon 5 polymorphism is associated with impaired IL-7Rα splicing and protection against tuberculosis in Ghana
43. Assessment and Treatment of Pain during Treatment of Buruli Ulcer
44. A re-evaluation of the origin of hepatitis C virus genotype 2 in West Africa
45. Pain Associated with Wound Care Treatment among Buruli Ulcer Patients from Ghana and Benin
46. Buruli Ulcer Control in a Highly Endemic District in Ghana: Role of Community-Based Surveillance Volunteers
47. Epidemiology of Mansonella perstans in the middle belt of Ghana.
48. Persisting Social Participation Restrictions among Former Buruli Ulcer Patients in Ghana and Benin
49. Psychometric Properties of the Participation Scale among Former Buruli Ulcer Patients in Ghana and Benin
50. Reply to “Compliance with Antimicrobial Therapy for Buruli Ulcer”
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.